Relapse Of Severe Asthma Exacerbations After Cessation Of Omalizumab Treatment - Real Life Data

被引：0
|
作者：
Kuprys-Lipinska, Izabela R. [1 ]
Kuna, Piotr [1 ]
机构：
[1] Med Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2013.12.026
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
2
引用
收藏
页码：AB1 / AB1
页数：1
相关论文
共 50 条
  • [31] Total and free IgE in evolution of severe asthma after omalizumab treatment
    Vennera, Maria del Carmen
    Pascal, Mariona
    Nunez, Ebymar Arismendi
    Picado, Cesar
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [33] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Carlos A. Torres-Duque
    Jaime Ocampo-Gómez
    Mauricio Morales Castillo
    Diana Cano-Rosales
    Ángela Giraldo-Montoya
    Freddy Rodríguez
    Isabel Palacios-Ortega
    Mauricio Durán-Silva
    Humberto Reynales
    Elizabeth García
    BMC Pulmonary Medicine, 22
  • [34] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Torres-Duque, Carlos A.
    Ocampo-Gomez, Jaime
    Castillo, Mauricio Morales
    Cano-Rosales, Diana
    Giraldo-Montoya, Angela
    Rodriguez, Freddy
    Palacios-Ortega, Isabel
    Duran-Silva, Mauricio
    Reynales, Humberto
    Garcia, Elizabeth
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [35] Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years
    Gemicioglu, B.
    Civici, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [36] Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
    Chaudhuri, Rekha
    Heaney, Liam G.
    Gallagher, Nicola
    Brightling, Christopher E.
    Menzies-Gow, Andrew N.
    Mansur, Adel H.
    Niven, Robert
    Cowan, Douglas C.
    Lee, Wai-ting N.
    McSharry, Charles
    Shepherd, Malcolm
    Patterson, Christopher C.
    Yang, Jieqiong F.
    Thomson, Neil C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] Real life data on treatment response to mepolizumab in patients with severe eosinophilic asthma
    Ntakoula, M.
    Fokoloros, C.
    Pasali, M.
    Aggelides, X.
    Makris, M.
    ALLERGY, 2019, 74 : 446 - 446
  • [38] Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
    Solidoro, Paolo
    Patrucco, Filippo
    de Blasio, Francesca
    Brussino, Luisa
    Bellocchia, Michela
    Dassetto, Davide
    Pivetta, Emanuele
    Riccio, Annamaria
    Heffler, Enrico
    Canonica, Walter
    Rolla, Giovanni
    Bucca, Caterina
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [39] Efficacy of mepolizumab in reducing exacerbations in patients with severe eosinophilic asthma who would be eligible for omalizumab treatment
    Albers, F. C.
    Price, R. G.
    Yancey, S. W.
    Bradford, E.
    ALLERGY, 2016, 71 : 66 - 67
  • [40] Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study
    Tiotiu, A.
    Oster, J. P.
    Roux, P. R.
    Nguyen Thi, P. L.
    Peiffer, G.
    Bonniaud, P.
    Daiphin, J. C.
    de Blay, F.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (01) : 49 - 57
12345